MedTrace Logo

Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC

NCT04855331 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-05-09

No results posted yet for this study

Summary

The aim of this study is to evaluate the safety and efficacy of laparoscopic versus open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic cancer

Conditions

Interventions

PROCEDURE

Laparoscopic pancreatoduodenectomy

Laparoscopic pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic cancer.

PROCEDURE

Open pancreatoduodenectomy

Open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic cancer.

Sponsors & Collaborators

  • The Third Affiliated Hospital of Soochow University

    collaborator OTHER

  • Qilu Hospital of Shandong University

    collaborator OTHER

  • West China Hospital

    collaborator OTHER

  • Tongji Hospital

    collaborator OTHER

  • Fujian Provincial Hospital

    collaborator OTHER

  • Zhejiang Provincial People's Hospital

    collaborator OTHER

  • Fudan University

    lead OTHER

Principal Investigators

  • Xianjun Yu, MD, PhD · Fudan University

  • Xiaowu Xu, MD · Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-15
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04855331 on ClinicalTrials.gov